TrialAnnals of oncology : official journal of the European Society for Medical Oncology2016

Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial.

N Harbeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.